Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae

References

• Martirosov DM, Lodise TP. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae. Diagn Microbiol Infect Dis. 2016;85:266–275.
   PubMed Web of Science ®Google Scholar
• Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682–707.
   PubMed Web of Science ®Google Scholar
• Doi Y, Paterson DL. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med. 2015;36:74–84.
   PubMed Web of Science ®Google Scholar
• Kelesidis T, Karageorgopoulos DE, Kelesidis I, et al. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother. 2008;62:895–904.
   PubMed Web of Science ®Google Scholar
• Peterson LR. A review of tigecycline – the first glycylcycline. Int J Antimicrob Agents. 2008;32(Suppl 4):S215–S222.
   PubMed Web of Science ®Google Scholar
• FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm369580.htm.
   Google Scholar
• Mouloudi E, Massa E, Piperidou M, et al. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study. Transplant Proc. 2014;46:3219–3221.
   PubMed Web of Science ®Google Scholar
• Sbrana F, Malacarne P, Viaggi B, et al. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit. Clin Infect Dis. 2013;56:697–700.
   PubMed Web of Science ®Google Scholar
• Balandin Moreno B, Fernández Simón I, Pintado García V, et al. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients. Scand J Infect Dis. 2014;46:175–180.
   PubMed Web of Science ®Google Scholar
• Burkhardt O, Rauch K, Kaever V, et al. Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint. Int J Antimicrob Agents. 2009;34:101–102.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-sixth Informational Supplement (M100-S26). 2016, CLSI, Wayne, PA, USA.
   Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.0, 2017 [Internet]. Available from: http://www.eucast.org.
   Google Scholar
• Chavda KD, Satlin MJ, Chen L, et al. Evaluation of a Multiplex PCR assay to rapidly detect Enterobacteriaceae with a broad range of β-Lactamases directly from perianal swabs. Antimicrob Agents Chemother. 2016;60:6957–6961.
   PubMed Web of Science ®Google Scholar
• Rubino CM, Forrest A, Bhavnani SM, et al. Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia. Antimicrob Agents Chemother. 2010;54:5180–5186.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Takano K, Matsuyama N, et al. Pharmacokinetic characteristics of minocycline in debilitated elderly patient. Am J Ther. 1999;6:157–160.
   PubMedGoogle Scholar
• Andes D, Craig W. Pharmacokinetics and pharmacodynamics of tetracyclines. In: Nightingale CH, editor. Antimicrobial pharmacodynamics in theory and clinical practice. 2nd ed. New York: Informa Healthcare; 2007. p. 267–278.
   Google Scholar
• Wyeth Pharmaceuticals Inc. Tygacil (tigecycline) for injection. Philadelphia (PA): Wyeth Pharmaceuticals Inc.; 2013.
   Google Scholar
• Wei C, Ni W, Cai X, et al. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia. Infect Dis (Lond). 2015;47:846–851.
   PubMed Web of Science ®Google Scholar
• Bhavnani SM, Rubino CM, Hammel JP, et al. Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline. Antimicrob Agents Chemother. 2012;56:1065–1072.
   PubMed Web of Science ®Google Scholar
• Drusano GL, Preston SL, Hardalo C, et al. Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint. Antimicrob Agents Chemother. 2001;45:13–22.
   PubMed Web of Science ®Google Scholar
• Grundmann H, Glasner C, Albiger B, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17:153–163.
   PubMed Web of Science ®Google Scholar
• Sader HS, Castanheira M, Flamm RK, et al. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013). Diagn Microbiol Infect Dis. 2015;83:183–186.
   PubMed Web of Science ®Google Scholar
• Ni W, Han Y, Liu J, et al. Tigecycline treatment for carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e3126.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61–e111.
   PubMed Web of Science ®Google Scholar
• Xie J, Wang T, Sun J, et al. Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation. Int J Infect Dis. 2014;18:62–67.
   PubMed Web of Science ®Google Scholar
• Di Carlo P, Gulotta G, Casuccio A, et al. KPC – 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients. BMC Anesthesiol. 2013;13:13.
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Matthaiou DK, Falagas ME, et al. Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. Infect Dis (Lond). 2015;47:751–753.
   PubMed Web of Science ®Google Scholar
• Ramirez J, Dartois N, Gandjini H, et al. Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia. Antimicrob Agents Chemother. 2013;57:1756–1762.
   PubMed Web of Science ®Google Scholar
• Pogue JM, Neelakanta A, Mynatt RP, et al. Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clin Infect Dis. 2014;59:S388–S393.
   PubMed Web of Science ®Google Scholar
• Rempex Pharmaceuticals, Inc. Minocin (minocycline for injection) package insert. Philadelphia (PA): Wyeth Pharmaceuticals Inc; 2010.
   Google Scholar
• Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14:498–509.
   PubMed Web of Science ®Google Scholar
• Kmeid JG, Youssef MM, Kanafani ZA, et al. Combination therapy for Gram-negative bacteria: what is the evidence? Expert Rev Anti Infect Ther. 2013;11:1355–1362.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017;17:726–734.
   PubMed Web of Science ®Google Scholar